News & Information For Arrhythmia Clinicians
Atrial fibrillation (AFib) is often asymptomatic--until it leads to complications or a stroke. In the US and EU, the annual economic burden of AFib and AFib-related stroke reaches into the billions ($/€), but governmental policies and clinical guidelines vary. To understand what works, the BMS–Pfizer Alliance conducted a comprehensive policy analysis across 10 countries with known clinical and public health AFib interventions, and identified actions for developing an effective health response, as well as emerging tools to support these efforts.
No time for silence: exploring policy approaches to investment in stroke prevention in France, Germany, Italy, Spain and the UK is an independent report written by The Economist Intelligence Unit, sponsored by The Bristol Myers Squibb–Pfizer Alliance. The report considers policy and investment efforts around best practices for preventing stroke including resources for education, awareness and detection. To better understand variations in European policy, the research has been conducted across five major countries: France, Germany, Italy, Spain and the UK
To dowlond the report, click here
National Cardiac Audit Programme Annual Report for Patients
This patient report is designed as a companion to the 2019 National Cardiac Audit Programme (NCAP) report produced by the National Institute for Cardiovascular Outcomes Research (NICOR), which has been carrying out national cardiac audits on behalf of the Healthcare Quality Improvement Partnership (HQIP) since 2011. NICOR is hosted by Barts Health NHS Trust. The primary aim of NCAP is to support and drive quality improvement within hospitals. For this reason our annual report is aimed at those with some level of clinical knowledge. This patient report is intended to be accessible to all patients, family members, carers and members of the public.
Click here to read.
National Cardiac Audit Programme Annual Report
The National Cardiac Audit Programme 2019 Annual Report covers over 300,000 records across five clinical areas: Congenital Heart Disease, Heart Attack, Percutaneous Coronary Interventions (PCI), Adult Surgery and Heart Failure. It highlights quality improvement opportunities under the themes of the need for timely care, the need for specialised care and the need for evidence-based care delivered equitably.
Click here to read.
Against the Odds: Successfully Scaling Innovation in the NHS' report publication
The spread of innovation is a continuous quest. Whether under the guise of scaling up new products or practices, reducing variation or high-quality care for all, the pursuit of equitable access to optimal care has been a preoccupation of healthcare services in the UK since Aneurin Bevan spoke in the 1946 NHS Bill of the ‘contract with the British people…that we should universalise the best, that we shall promise every citizen in this country the same standard of service’.
Trudie Lobban MBE, Founder of Arrhythmia Alliance quotes on page 34 - The spread of Implantable Cardioverter-Defibrillators (ICDs).
Click here to read.
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis- June 2017
A national screening programme for atrial fibrillation is likely to represent a cost-effective use of resources, with systematic opportunistic screening more likely to be cost-effective than systematic population screening. Nurse pulse palpation or modified blood pressure monitors would be appropriate screening tests, with confirmation by diagnostic 12-lead electrocardiography interpreted by a trained GP, with referral to a specialist in the case of an unclear diagnosis. Implementation strategies to operationalise uptake of systematic opportunistic screening in primary care should accompany any screening recommendations.
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)- June 2017
Cardiac tachyarrhythmias are recurrent or chronic and in some cases life-threatening conditions. Heart rhythm disturbances are often highly symptomatic and the psychological impact of the disease can be significant. Patients' beliefs and knowledge about their health (and illness), medications, and healthcare they receive are important determinants of whether or not they accept recommended treatments; influence their coping responses to their illness and treatment; adherence to recommended therapy; and ultimately affects health outcomes. Incorporation of patients' values and preferences for therapy should now be considered as an integral part of the decision-making process and treatment strategy. It is important to acknowledge and understand the impact of cardiac tachyarrhythmias on the patient. To address this issue, a Task Force was convened by the European Heart Rhythm Association (EHRA), and endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE), with the remit to comprehensively review the published evidence available, to publish a joint consensus document on patient values and preferences for the management of cardiac tachyarrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice.
Managing reversal of direct oral anticoagulants in emergency situations
Walter Ageno; Harry R. Büller; Anna Falanga; Werner Hacke; Jeroen Hendriks; Trudie Lobban; Jose Merino; Ivan S. Milojevic; Francisco Moya; H. Bart van der Worp; Gary Randall; Konstantinos Tsioufis; Peter Verhamme; A. John Camm - 2016
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and stroke prevention in patients with atrial fibrillation (AF). However, the mechanisms by which anticoagulants confer therapeutic benefit also increase the risk of bleeding. As such, reversal strategies are critical.
This guide is not for direct distribution to patients and is intended to support healthcare professional and patient discussion on atrial fibrillation (AF).
It will take about ten minutes and will help you make the most of the consultation time.
Management of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia and Vasovagal Syncope
Satish Raj, Robert Sheldon - 2016
Syncope and palpitations are two common clinical presentations, and both pose difficulties in the approach to their management. They are both symptoms of a number of syndromes, and an efficient approach with targeted therapy is challenging. Cardiac arrhythmia specialists, who lack a compact and accessible guide to management, see many patients with these symptoms in consultation.
An independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
A peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of arrhythmia and electrophysiology.
WiSE CRT System
The WiSE CRT System is designed to overcome the limitations of traditional CRT pacing. It provides wireless, left ventricular (LV), endocardial pacing in patients with issues related to standard epicardial coronary sinus (CS) pacing leads.
Arrhythmia & Electrophysiology Review (AER)
Demosthenes Katritsis - 2017
AER is a tri-annual, peer reviewed journal aimed at assisting time-pressured general and specialist cardiologists to stay abreast of key advances and opinion in the arrhythmia and electrophysiology sphere.
Led by Editor-in-Chief Demosthenes Katritsis, supported by Section Editors Andrew Grace (Arrhythmia Mechanisms/Basic Science), Karl-Heinz Kuck (Clinical Electrophysiology and Ablation) and Angelo Auricchio (Implantable Devices) and underpinned by an editorial board of world-renowned physicians, AER comprises peer-reviewed articles that aim to provide timely update on the most pertinent issues in the field.
Principles of External Defibrillators
Hugo Delgado, Jorge Toquero, Cristina Mitroi, Victor Castro and Ignacio Fernandez Lozano - 2013
An open access publication on the importance of defibrillation and the development of external devices which charts everything from the history of the defibrillator through to the science of defibrillation and studies on the impact of early defibrillation on survival rates in cases of out-of-hospital cardiac arrest.
Anatomy for Cardiac Electrophysiologists
Sabine Ernst and S. Yen Ho - 2012
A superbly illustrated new book by Sabine Ernst and S. Yen Ho that integrates cardiac anatomy and state-of-the-art imaging techniques to guide readers to a comprehensive understanding of both normal cardiac anatomy and the structures associated with complex heart disease.
Heart - Underdrive pacing to terminate ventricular tachycardia
Richard Bond, Paul W X Foley, Yaver Bashir - 2012
An 81 year old man was admitted in haemodynamically stable monomorphic ventricular tachycardia (VT). He had previously suffered a myocardial infarct and later developed remote monomorphic VT (rate 180 bpm, cycle lenght 333 ms) requiring an implantable defibrillator (St Jude Current DR) and treatment with amiodarone.
Heart - The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated
Jane Caldwell, Natalie Moreton, Naz Khan, Lauren Kerzin-Storrar, Kay Metcalfe, William Newman, Clifford J Garratt - 2012
Objective - Following national guidance on management of sudden unexplained death (SUD) in the young, inherited cardiac conditions (ICC) clinics were established to identify and treat relatives thought to be at increased risk.
Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing
Vivek Y. Reddy, MD, Marc A. Miller, MD, Petr Neuzil, MD, Peter Søgaard, MD, Christian Butter, MD, Martin Seifert, MD, Peter Paul Delnoy, MD, Lieselot van Erven, MD, Martin Schalji, MD, Lucas V.A. Boersma, MD, Sam Riahi, MD, PHD - 2017
A total of 30% to 40% of patients with congestive heart failure eligible for cardiac resynchronization therapy (CRT) either do not respond to conventional CRT or remain untreated due to an inability or impediment to coronary sinus (CS) lead implantation. The WiSE-CRT system (EBR Systems, Sunnyvale, California) was developed to address this at-risk patient population by performing biventricular pacing via a wireless left ventricular (LV) endocardial pacing electrode.